(MENAFN- EIN Presswire) Biosensors Market
The growth of global biosensors market is due to surge in demand for home care medical devices and increased use of biosensors in these devices across the globe
PORTLAND, OR, UNITED STATES, February 7, 2023 /einpresswire.com / -- The biosensors market is a rapidly growing industry that involves the development and production of devices that use biological materials (such as enzymes, antibodies, and cells) to detect and measure various analytes, such as glucose, lactate, and cholesterol. Biosensors have a wide range of applications in healthcare, food safety, environmental monitoring, and many other fields. Key drivers of growth in the biosensors market include the increasing incidence of chronic diseases, growing awareness of the benefits of preventative healthcare, and advancements in biotechnology and materials science.
The biosensors market was valued at $17,500.0 million in 2018 and is expected to reach $38,600.2 million by 2026, registering a CAGR of 10.4% from 2019 to 2026.
Drivers, restraints, and opportunities-
Increase in chronic diseases such as diabetes, rise in R&D investments, and development of nanotechnology-based biosensors drive the growth of the global biosensors market. However, high cost associated with research and development (R&D) hinders the market growth. On the other hand, technological advancements in biosensors to make it user friendly are anticipated to offer new opportunities in the coming years.
Request Sample Report at:
Covid-19 Scenario-
During the coronavirus outcome, the R&D activities in biosensors have been observed to be increased.
A team of researchers at the Swiss Federal Laboratories for Materials Science and Technology (Empa) and ETH Zurich (Swiss Federal Institute of Technology in Zürich) are investigating to develop a reliable sensor to detect COVID-19 in highly populated areas, like train stations and hospitals.
Leading market players
1. Abbott Laboratories
2. AgaMatrix Holdings LLC
3. DowDupont Inc. (DuPont de Nemours, Inc.)
4. F. Hoffmann-La Roche Ltd.
5. General Electric (Biacore, Inc.)
6. LifeScan, Inc.
7. Medtronic Plc.
8. Nova Biomedical
9. PHC Holdings Co., Ltd. (Ascensia Diabetes Care Holdings AG)
10. Siemens Healthcare.
The non-wearable biosensors segment to maintain its lead status-
Based on product, the non-wearable biosensors segment accounted for more than half of the global biosensors market in 2018, and is expected to maintain its lead status in terms of revenue throughout the forecast period. Upsurge in use of these sensors in nonclinical applications for real-time on-site monitoring of various production processes drives the growth of the segment. However, the wearable biosensors is estimated to portray the highest CAGR of 11.1% from 2019 to 2026. The growth of the segment is driven by its ability to deliver continuous, real-time physiological information through noninvasive measurements of biochemical markers present in biofluids including sweat, tears, saliva, and interstitial fluid.
The electrochemical biosensors segment to maintain its leadership position-
Based on technology, the electrochemical biosensors segment contributed to the highest market share with more than one third of the global biosensors market in 2018, and is estimated to maintain its leadership position during the forecast period. This is attributed to the accurate sensitivity, and faster response by this technology. However, the optical biosensors segment is estimated to generate the fastest CAGR of 11.5% from 2019 to 2026. This is attributed to increase in adoption of optical biosensors in medical field and its advantages over other analytical techniques.
For Purchase Enquiry at:
North America is anticipated to dominate the market by 2026-
Based on region, North America accounted for the highest share based on revenue, holding for more than two-fifths of the global biosensors market in 2018, and is projected to maintain its dominant position throughout the forecast period. The growth in this region is driven by the factors such as increase in government funds for conducting research toward development of advanced biosensors for various applications. However, the region across Asia-Pacific is estimated to generate the fastest CAGR of 12.2% from 2019 to 2026. This is attributed to the increase in per capita income in many countries, rise in government initiatives for improvement of the healthcare sector, and surge in focus of leading manufacturers on expanding their geographic presence in this region.
Key findings of the study –
By technology, the electrochemical biosensors segment accounted for the highest market share of 28% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
By product, the non-wearable segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.
By region, North America was the major shareholder and accounted for the highest share of 42% in 2018.
Asia-Pacific is expected to grow at a CAGR of 6.1% during the forecast period.
Important Questions Being Answered by This Market Report Are –
Q 1. Does the biosensor market report provide Value Chain Analysis?
Q 2. What are the key trends in the biosensor market report?
Q 3. What are the market values / growth % of emerging countries?
Q 4. Which market holds the maximum market share of the biosensor market?
Request for Customization:
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of“Market Research Reports” and“Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
facebook
twitter
linkedin